239 related articles for article (PubMed ID: 23688621)
1. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability.
Niu X; Wan L; Hou Z; Wang T; Sun C; Sun J; Zhao P; Jiang T; Wang S
Int J Pharm; 2013 Aug; 452(1-2):382-9. PubMed ID: 23688621
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous carbon with spherical pores as a carrier for celecoxib with needle-like crystallinity: improve dissolution rate and bioavailability.
Zhu W; Zhao Q; Sun C; Zhang Z; Jiang T; Sun J; Li Y; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():13-20. PubMed ID: 24863191
[TBL] [Abstract][Full Text] [Related]
3. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
4. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.
Hong S; Shen S; Tan DC; Ng WK; Liu X; Chia LS; Irwan AW; Tan R; Nowak SA; Marsh K; Gokhale R
Drug Deliv; 2016; 23(1):316-27. PubMed ID: 24853963
[TBL] [Abstract][Full Text] [Related]
5. Inclusion of celecoxib into fibrous ordered mesoporous carbon for enhanced oral bioavailability and reduced gastric irritancy.
Zhao P; Jiang H; Jiang T; Zhi Z; Wu C; Sun C; Zhang J; Wang S
Eur J Pharm Sci; 2012 Apr; 45(5):639-47. PubMed ID: 22251657
[TBL] [Abstract][Full Text] [Related]
6. Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing.
Zhang M; Li H; Lang B; O'Donnell K; Zhang H; Wang Z; Dong Y; Wu C; Williams RO
Eur J Pharm Biopharm; 2012 Nov; 82(3):534-44. PubMed ID: 22974985
[TBL] [Abstract][Full Text] [Related]
7. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
[TBL] [Abstract][Full Text] [Related]
8. Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate.
Bai A; Wu C; Liu X; Lv H; Xu X; Cao Y; Shang W; Hu L; Liu Y
Drug Des Devel Ther; 2018; 12():2129-2138. PubMed ID: 30022811
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrate.
Cho YD; Park YJ
Arch Pharm Res; 2014 Feb; 37(2):193-203. PubMed ID: 23754165
[TBL] [Abstract][Full Text] [Related]
10. Improved dissolution rate and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering.
Wang P; Luo Q; Miao Y; Ying L; He H; Cai C; Tang X
Drug Dev Ind Pharm; 2012 Nov; 38(11):1344-53. PubMed ID: 22283480
[TBL] [Abstract][Full Text] [Related]
11. Impregnation of Fenofibrate on mesoporous silica using supercritical carbon dioxide.
Bouledjouidja A; Masmoudi Y; Van Speybroeck M; Schueller L; Badens E
Int J Pharm; 2016 Feb; 499(1-2):1-9. PubMed ID: 26732521
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Performance of Fenofibrate Formulated With Ordered Mesoporous Silica Versus 2-Marketed Formulations: A Comparative Bioavailability Study in Beagle Dogs.
Bukara K; Schueller L; Rosier J; Daems T; Verheyden L; Eelen S; Martens JA; Van den Mooter G; Bugarski B; Kiekens F
J Pharm Sci; 2016 Aug; 105(8):2381-5. PubMed ID: 27364460
[TBL] [Abstract][Full Text] [Related]
13. Increasing the dissolution rate and oral bioavailability of the poorly water-soluble drug valsartan using novel hierarchical porous carbon monoliths.
Zhang Y; Che E; Zhang M; Sun B; Gao J; Han J; Song Y
Int J Pharm; 2014 Oct; 473(1-2):375-83. PubMed ID: 25051114
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
Ige PP; Baria RK; Gattani SG
Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
[TBL] [Abstract][Full Text] [Related]
15. Preparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailability.
Zhang L; Chai G; Zeng X; He H; Xu H; Tang X
Drug Dev Ind Pharm; 2010 Sep; 36(9):1054-63. PubMed ID: 20818965
[TBL] [Abstract][Full Text] [Related]
16. Enhancing in vitro dissolution and in vivo bioavailability of fenofibrate by solid self-emulsifying matrix combined with SBA-15 mesoporous silica.
Quan G; Wu Q; Zhang X; Zhan Z; Zhou C; Chen B; Zhang Z; Li G; Pan X; Wu C
Colloids Surf B Biointerfaces; 2016 May; 141():476-482. PubMed ID: 26896653
[TBL] [Abstract][Full Text] [Related]
17. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
[TBL] [Abstract][Full Text] [Related]
18. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.
Yousaf AM; Mustapha O; Kim DW; Kim DS; Kim KS; Jin SG; Yong CS; Youn YS; Oh YK; Kim JO; Choi HG
Int J Nanomedicine; 2016; 11():213-21. PubMed ID: 26834471
[TBL] [Abstract][Full Text] [Related]
19. Effects of Polymer/Surfactant as Carriers on the Solubility and Dissolution of Fenofibrate Solid Dispersion.
Yang B; Wu L; Ke J; Zhou L; Chen M; Li S; Feng X
AAPS PharmSciTech; 2019 Feb; 20(3):102. PubMed ID: 30723877
[TBL] [Abstract][Full Text] [Related]
20. Highly ordered mesoporous carbon nanomatrix as a new approach to improve the oral absorption of the water-insoluble drug, simvastatin.
Zhang Y; Wang H; Gao C; Li X; Li L
Eur J Pharm Sci; 2013 Aug; 49(5):864-72. PubMed ID: 23791638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
